{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:05:19Z","timestamp":1793520319858,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["TA-GT-0321-0802-COLUTRAP"],"award-info":[{"award-number":["TA-GT-0321-0802-COLUTRAP"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY018213"],"award-info":[{"award-number":["R01EY018213"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY027285"],"award-info":[{"award-number":["R24EY027285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY024698"],"award-info":[{"award-number":["R01EY024698"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24EY028758"],"award-info":[{"award-number":["R24EY028758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30EY019007"],"award-info":[{"award-number":["5P30EY019007"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01EY030580"],"award-info":[{"award-number":["U01EY030580"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01EY034590"],"award-info":[{"award-number":["U01EY034590"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY033770"],"award-info":[{"award-number":["R01EY033770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.eclinm.2025.103430","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T02:38:40Z","timestamp":1755139120000},"page":"103430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-2366","authenticated-orcid":false,"given":"Byron L.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliy","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninel Z.","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai H.","family":"Chavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Batabyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananta","family":"Ayyagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozhat","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Von Tress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Piltz-Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-730X","authenticated-orcid":false,"given":"Najam A.","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-1614","authenticated-orcid":false,"given":"David S.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3921-608X","authenticated-orcid":false,"given":"Allen C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samarendra K.","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103430_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng1193-308","article-title":"A gene for Stargardt\u2019s disease (fundus flavimaculatus) maps to the short arm of chromosome 1","volume":"5","author":"Kaplan","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.eclinm.2025.103430_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng0397-236","article-title":"A photoreceptor cell-specific ATP-Binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy","volume":"15","author":"Allikmets","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.eclinm.2025.103430_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/ddh048","article-title":"Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence","volume":"13","author":"Cideciyan","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eclinm.2025.103430_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.61.4.13","article-title":"Progressive choriocapillaris impairment in ABCA4 maculopathy is secondary to retinal pigment epithelium atrophy","volume":"61","author":"Jauregui","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.eclinm.2025.103430_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00006982-200412000-00013","article-title":"Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus","volume":"24","author":"Oh","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.eclinm.2025.103430_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajo.2012.09.011","article-title":"Clinical phenotypes and prognostic full-field electroretinographic findings in Stargardt disease","volume":"155","author":"Zahid","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib7","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMicm1913388","article-title":"Stargardt juvenile macular degeneration","volume":"382","author":"Oh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103430_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/a-1057-9939","article-title":"ABCA4-associated Stargardt disease","volume":"237","author":"Khan","year":"2020","journal-title":"Klin Monatsbl\u00e4tter Augenheilkd"},{"key":"10.1016\/j.eclinm.2025.103430_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017301","article-title":"Gene therapy of ABCA4-associated diseases","volume":"5","author":"Auricchio","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eclinm.2025.103430_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.preteyeres.2010.01.001","article-title":"Genetics and molecular pathology of Stargardt-like macular degeneration","volume":"29","author":"Vasireddy","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.eclinm.2025.103430_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MOP.0000000000000026","article-title":"Advances in the genetics of eye diseases","volume":"25","author":"Chan","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.eclinm.2025.103430_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","article-title":"Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options","volume":"101","author":"Tanna","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib13","first-page":"495","article-title":"Stargardt macular dystrophy and therapeutic approaches","volume":"108","author":"Fujinami","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.exer.2010.03.021","article-title":"Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease","volume":"91","author":"Chen","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.eclinm.2025.103430_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","article-title":"The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) studies: design and baseline characteristics: ProgStar Report No. 1","volume":"123","author":"Strauss","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2025.103430_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaophthalmol.2017.4152","article-title":"Progression of Stargardt disease as determined by fundus autofluorescence in the retrospective progression of Stargardt disease study (ProgStar report no. 9)","volume":"135","author":"Strauss","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13578-024-01272-y","article-title":"The ABCs of Stargardt disease: the latest advances in precision medicine","volume":"14","author":"Zaydon","year":"2024","journal-title":"Cell Biosci"},{"key":"10.1016\/j.eclinm.2025.103430_bib18","series-title":"Retinal degenerative diseases: mechanisms and experimental therapy","first-page":"719","article-title":"Gene therapy for Stargardt disease associated with ABCA4 gene","author":"Han","year":"2014"},{"key":"10.1016\/j.eclinm.2025.103430_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2025.103430_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.omtn.2023.02.032","article-title":"Efficient correction of Abca4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients","volume":"32","author":"Siles","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.eclinm.2025.103430_bib21","first-page":"041412","article-title":"Restoring vision in mice with retinal degeneration using multicharacteristic opsin","volume":"4","author":"Wright","year":"2017","journal-title":"Neurophotonics"},{"key":"10.1016\/j.eclinm.2025.103430_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41434-020-00200-2","article-title":"Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice","volume":"28","author":"Batabyal","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.eclinm.2025.103430_bib23","series-title":"Handbook of basic and clinical ocular pharmacology and therapeutics","first-page":"581","author":"Mohanty","year":"2022"},{"key":"10.1016\/j.eclinm.2025.103430_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/tvst.13.10.25","article-title":"Multi-characteristic opsin therapy to functionalize retina, attenuate retinal degeneration, and restore vision in mouse models of retinitis pigmentosa","volume":"13","author":"Batabyal","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103430_bib25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jop.2024.0084","article-title":"Efficacy of intravitreal multi-characteristic opsin (MCO-010) optogenetic gene therapy in a mouse model of leber congenital amaurosis","volume":"40","author":"Dibas","year":"2024","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.eclinm.2025.103430_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2025.103430_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3720","article-title":"Safety of intravitreally delivered AAV2 vector-mediated multi-characteristic opsin genetic construct in wild type beagle dogs","volume":"26","author":"Mohanty","year":"2024","journal-title":"J Gene Med"},{"key":"10.1016\/j.eclinm.2025.103430_bib28","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1111\/jcmm.16823","article-title":"Biodistribution of adeno-associated virus type 2 carrying multi-characteristic opsin in dogs following intravitreal injection","volume":"25","author":"Tchedre","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103430_bib29","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ymthe.2025.03.031","article-title":"A synthetic opsin restores vision in patients with severe retinal degeneration","volume":"33","author":"Mohanty","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.eclinm.2025.103430_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Nussenblatt","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib48","first-page":"1","article-title":"Design and development of a multi-luminance shape discrimination test for assessing object recognition ability of visually impaired individuals","volume":"15","author":"Carlson","year":"2024","journal-title":"EC Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ophtha.2023.06.010","article-title":"Prognostication in Stargardt disease using fundus autofluorescence: improving patient care","volume":"130","author":"Varela","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2025.103430_bib32","article-title":"The role of multimodal imaging and vision function testing in ABCA4-related retinopathies and their relevance to future therapeutic interventions","volume":"13","author":"Al-Khuzaei","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.oret.2023.08.017","article-title":"Classification and growth rate of chorioretinal atrophy after voretigene neparvovec-Rzyl for RPE65-mediated retinal degeneration","volume":"8","author":"Bommakanti","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.eclinm.2025.103430_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-2-7","article-title":"Cone rod dystrophies","volume":"2","author":"Hamel","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.eclinm.2025.103430_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/7.3.355","article-title":"Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR","volume":"7","author":"Cremers","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eclinm.2025.103430_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bjophthalmol-2019-315086","article-title":"Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options","volume":"104","author":"Rahman","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eclinm.2025.103430_bib37","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1167\/iovs.15-16763","article-title":"Flecks in recessive Stargardt disease: short-wavelength autofluorescence, near-infrared autofluorescence, and optical coherence tomography","volume":"56","author":"Sparrow","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.eclinm.2025.103430_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10863-007-9118-6","article-title":"ATP-binding cassette transporter ABCA4: molecular properties and role in vision and macular degeneration","volume":"39","author":"Molday","year":"2007","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.eclinm.2025.103430_bib39","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1038\/s41467-022-34353-y","article-title":"Electronic photoreceptors enable prosthetic visual acuity matching the natural resolution in rats","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2025.103430_bib40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.ophtha.2017.04.026","article-title":"Visual acuity change over 12 months in the prospective progression of atrophy secondary to Stargardt disease (ProgStar) study: progstar report number 6","volume":"124","author":"Kong","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2025.103430_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajo.2021.04.015","article-title":"The progression of Stargardt disease using volumetric hill of vision analyses over 24 months: ProgStar Report No. 15","volume":"230","author":"Sch\u00f6nbach","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103430_bib42","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.ymthe.2025.04.018","article-title":"Response: promise and open questions of optogenetic vision restoration by MCO","volume":"33","author":"Mohanty","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.eclinm.2025.103430_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.11","article-title":"Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice","volume":"3","author":"Marangoni","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.eclinm.2025.103430_bib44","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.ymthe.2023.03.035","article-title":"Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks","volume":"31","author":"McGrady","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.eclinm.2025.103430_bib45","first-page":"307","article-title":"Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates","volume":"23","author":"Calkins","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.eclinm.2025.103430_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40259-021-00468-9","article-title":"Safety of intravitreal gene therapy for treatment of subjects with Leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: the REVEAL study","volume":"35","author":"Vignal-Clermont","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.eclinm.2025.103430_bib47","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:23:26Z","timestamp":1772915006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"alternative-id":["S2589537025003621"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103430","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103430"}}